Mill Creek, WA, United States of America

Hua Chee Ooi

USPTO Granted Patents = 11 


 

Average Co-Inventor Count = 7.8

ph-index = 9

Forward Citations = 405(Granted Patents)


Location History:

  • Kirkland, WA (US) (2011 - 2013)
  • Mill Creek, WA (US) (2014 - 2021)

Company Filing History:


Years Active: 2011-2021

Loading Chart...
Loading Chart...
Loading Chart...
11 patents (USPTO):Explore Patents

Title: **Innovations by Hua Chee Ooi: A Trailblazer in Quinazolinone Compounds**

Introduction

Hua Chee Ooi, an accomplished inventor based in Mill Creek, WA, has made significant contributions to the field of pharmaceuticals with a focus on quinazolinone compounds. With a total of 11 patents to his name, he has demonstrated a commitment to advancing medical science, particularly in the domain of inhibitors of phosphatidylinositol 3-kinase delta (PI3Kδ).

Latest Patents

Among his latest innovations are two noteworthy patents:

1. **Tert-butyl (S)-(1-(5-fluoro-4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)propyl)carbamate**: This patent discloses compounds that inhibit PI3Kδ activity and outlines methods for preparing these compounds. It serves as a precursor for synthesizing a specific compound that effectively targets PI3Kδ, playing a crucial role in immunological and inflammatory disorders.

2. **(S)-2-(1-aminopropyl)-5-fluoro-3-phenylquinazolin-4(3H)-one**: This invention similarly focuses on compounds that inhibit PI3Kδ, providing methods that harness this compound as a precursor for a specific inhibitor. The significance of this research lies in its potential to offer therapeutic options for various diseases related to immunity and inflammation.

Career Highlights

Hua Chee Ooi has established himself as a valuable asset in the pharmaceutical industry through his role at Icos Corporation. His research has been instrumental in the development of compounds that address critical health issues, thereby enhancing the therapeutic landscape for patients suffering from conditions linked to PI3Kδ activity.

Collaborations

Throughout his career, Hua has collaborated with esteemed colleagues such as Kerry W. Fowler and Danwen Huang. These partnerships have bolstered the innovative efforts at Icos Corporation, fostering an environment of collaboration that drives forward the goal of developing breakthrough medical solutions.

Conclusion

Hua Chee Ooi's impressive portfolio of patents and his dedication to pharmaceutical innovation highlight his role as a pioneering inventor in the field. His work on quinazolinone compounds not only showcases his talent but also emphasizes the importance of collaboration in achieving significant advancements in medical research and treatment solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…